enVVeno Medical Corporation
NVNO
Price:
$10
Market Cap:
$165.03K
enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In additi...[Read more]
Industry
Medical - Devices
IPO Date
2018-05-31
Stock Exchange
NASDAQ
Ticker
NVNO
PE Ratio
[-0.32]
ROE
[-66.39%]
Current Ratio
[11.89]
Dividend Yield
[0%]
Enterprise Value
[-1828970.00]
Dividend History
The ROE as of June 2026 (TTM) for enVVeno Medical Corporation (NVNO) is -66.39%
According to enVVeno Medical Corporation’s latest financial reports and current stock price. The company's current ROE is -66.39%. This represents a change of 304.54% compared to the average of -16.41% of the last 4 quarters.
enVVeno Medical Corporation (NVNO) Historical ROE (quarterly & annually)
How has NVNO ROE performed in the past?
The mean historical ROE of enVVeno Medical Corporation over the last ten years is -159.85%. The current -66.39% ROE has changed -58.47% with respect to the historical average. Over the past ten years (40 quarters), NVNO's ROE was at its highest in in the March 2020 quarter at 7.93%. The ROE was at its lowest in in the June 2020 quarter at -440.38%.
Average
-159.85%
Median
-57.73%
Minimum
-770.29%
Maximum
139.51%
enVVeno Medical Corporation (NVNO) ROE by Quarter and Year
Discovering the peaks and valleys of enVVeno Medical Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 109.67%
Maximum Annual ROE = 139.51%
Minimum Annual Increase = -1014.93%
Minimum Annual ROE = -770.29%
| Year | ROE | Change |
|---|---|---|
| 2025 | -71.77% | 38.68% |
| 2024 | -51.75% | 1.68% |
| 2023 | -50.90% | -20.09% |
| 2022 | -63.70% | 109.67% |
| 2021 | -30.38% | -76.40% |
| 2020 | -128.71% | -83.29% |
| 2019 | -770.29% | 20.27% |
| 2018 | -640.47% | -1014.93% |
| 2017 | 70.00% | -49.82% |
| 2016 | 139.51% | 54.86% |
enVVeno Medical Corporation (NVNO) Average ROE
How has NVNO ROE performed in the past?
The current ROE of enVVeno Medical Corporation (NVNO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-58.14%
5-year avg
-53.70%
10-year avg
-159.85%
enVVeno Medical Corporation (NVNO) ROE vs. Peers
How is NVNO’s ROE compared to its peers?
enVVeno Medical Corporation’s ROE is less than Allurion Technologies Inc. (44.17%), greater than Aethlon Medical, Inc. (-137.73%), greater than Co-Diagnostics, Inc. (-164.92%), greater than Vivos Therapeutics, Inc. (-2239.18%), less than Envoy Medical, Inc. (239.44%), greater than Ekso Bionics Holdings, Inc. (-177.40%), greater than Adagio Medical Holdings, Inc. (-382.50%), greater than Aytu BioPharma, Inc. (-148.91%), greater than GeoVax Labs, Inc. (-709.51%), greater than ProPhase Labs, Inc. (-157.67%),
| Company | ROE | Market cap |
|---|---|---|
| 44.17% | $4.98M | |
| -137.73% | $1.54M | |
| -164.92% | $4.79M | |
| -2239.18% | $3.37M | |
| 239.44% | $13.06M | |
| -177.40% | $28.63M | |
| -382.50% | $11.34M | |
| -148.91% | $17.41M | |
| -709.51% | $1.17M | |
| -157.67% | $378.96K |
Build a custom stock screener for enVVeno Medical Corporation (NVNO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like enVVeno Medical Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
enVVeno Medical Corporation (NVNO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like enVVeno Medical Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is enVVeno Medical Corporation's ROE?
How is the ROE calculated for enVVeno Medical Corporation (NVNO)?
What is the highest ROE for enVVeno Medical Corporation (NVNO)?
What is the 3-year average ROE for enVVeno Medical Corporation (NVNO)?
What is the 5-year average ROE for enVVeno Medical Corporation (NVNO)?
How does the current ROE for enVVeno Medical Corporation (NVNO) compare to its historical average?